Phaos Technology Holdings (Cayman) (POAS) Cash & Equivalents Growth (1y) (2025)

Phaos Technology Holdings (Cayman) (POAS) Cash & Equivalents Growth (1y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 4.15%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 24.05%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -7.50%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -7.71%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 156.03%
10 Phaos Technology Holdings (Cayman) 682,234.12 627,245.12 - -

Historic Data

Download Data
DateValue
Apr 30, 2025 -94.35%